NCT02151825View on ClinicalTrials.gov

Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
Gut MicrobiotaAdiposity
Interventions
DIETARY_SUPPLEMENT

Synbiotic

3 capsules per day containing 4 billion CFU of Bifidobacterium lactis BB-12, Lactobacillus acidophilus LA-5, Lactobacillus casei 431 and Saccharomyces boulardii in combination with prebiotics Inulin (1 g) and Galactooligosaccharides (100 mg)

OTHER

Placebo

3 capsules of Maltodextrin per day

Trial Locations (1)

78666

Texas State University, San Marcos

All Listed Sponsors
collaborator

Standard Process Inc.

INDUSTRY

lead

Texas State University, San Marcos

OTHER

NCT02151825 - Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects | Biotech Hunter | Biotech Hunter